Figure 5.
Impaired apoptosis in resistant compared with sensitive ALL cells. A defect localized upstream of the mitochondria may lead to decreased activation of downstream apoptotic parameters in resistant patients with ALL. Potential sites of defects are indicated with a cross. Decreased activation of apoptotic parameters is illustrated by the decreased size of the arrows in resistant compared with sensitive patients.